We are live on ! Find out more
ALPN

Alpine Immune Sciences Inc
ALPN

Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

48 hedge funds and large institutions have $145M invested in Alpine Immune Sciences Inc in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

50% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 10

9% more funds holding

Funds holding: 44 → 48 (+4)

10% less capital invested

Capital invested by funds: $160M → $145M (-$15.4M)

Holders
48
Holders Change
+4
Holders Change %
+9.09%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
15
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$3.74M
2
SCM
Soleus Capital Management
Connecticut
+$3.39M
3
APM
Avidity Partners Management
Texas
+$3.28M
4
Deutsche Bank
Deutsche Bank
Germany
+$3.05M
5
OM
Opaleye Management
Massachusetts
+$1.95M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$4.64M
2
FCM
Farallon Capital Management
California
-$2.52M
3
CCM
CAAS Capital Management
New York
-$1.87M
4
EI
EAM Investors
California
-$797K
5
Renaissance Technologies
Renaissance Technologies
New York
-$772K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
26
Boothbay Fund Management
New York
$390K +$329K +26,361 +253%
ECM
27
ExodusPoint Capital Management
New York
$385K -$672K -53,870 -60%
BlackRock
28
BlackRock
New York
$284K +$12.5K +1,001 +4%
HF
29
HRT Financial
New York
$250K +$294K +23,593 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$240K -$9.25K -742 -3%
Citadel Advisors
31
Citadel Advisors
Florida
$234K +$275K +22,030 New
Northern Trust
32
Northern Trust
Illinois
$211K +$1.4K +112 +0.6%
LRIA
33
Leonard Rickey Investment Advisors
Washington
$180K – – –
Qube Research & Technologies (QRT)
34
Qube Research & Technologies (QRT)
United Kingdom
$154K -$399K -31,994 -69%
VCP
35
Vista Capital Partners
Oregon
$152K -$249K -20,000 -58%
Barclays
36
Barclays
United Kingdom
$150K +$176K +14,105 New
HW
37
Hancock Whitney
Mississippi
$122K – – –
Goldman Sachs
38
Goldman Sachs
New York
$112K +$132K +10,577 New
HP
39
Hikari Power
Japan
$111K – – –
MIM
40
Monashee Investment Management
Massachusetts
$107K – – –
Citigroup
41
Citigroup
New York
$63K -$37.2K -2,980 -33%
Morgan Stanley
42
Morgan Stanley
New York
$57K -$4.64M -372,373 -99%
DWA
43
Dorsey Wright & Associates
California
$35.8K +$42.1K +3,380 New
Bank of America
44
Bank of America
North Carolina
$12K +$14.7K +1,178 New
TRCT
45
Tower Research Capital (TRC)
New York
$10K +$8.79K +705 +243%
UBS Group
46
UBS Group
Switzerland
$7K +$8.59K +689 New
Wells Fargo
47
Wells Fargo
California
$4K +$3.73K +299 +446%
FCM
48
Farallon Capital Management
California
– -$2.52M -200,000 Closed
CCM
49
CAAS Capital Management
New York
– -$1.87M -148,200 Closed
EI
50
EAM Investors
California
– -$797K -63,261 Closed
1
2
3

ALPN Hedge Fund Activity: Q1 2021 in Review

48 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q1 2021, worth a combined $145M — down 9.6% from $160M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new ALPN positions and 7 closed out — a net gain of 4 holders — while 15 added to existing stakes and 10 trimmed.

The largest buyer was Ikarian Capital, adding an estimated $3.74M. The largest seller was Morgan Stanley, cutting an estimated $4.64M.

  • 48 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q1 2021, up from 44 in Q4 2020.
  • Funds reported $145M of Alpine Immune Sciences Inc stock for Q1 2021, down 9.6% quarter-over-quarter.
  • 11 funds opened new Alpine Immune Sciences Inc positions in Q1 2021 and 7 closed out, a net change of +4 holders.
  • The largest Alpine Immune Sciences Inc buyer in Q1 2021 was Ikarian Capital, an estimated $3.74M added.
  • The largest Alpine Immune Sciences Inc seller in Q1 2021 was Morgan Stanley, an estimated $4.64M sold.

Based on aggregated 13F filings for Q1 2021.